<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02512809</url>
  </required_header>
  <id_info>
    <org_study_id>IRB14-00625</org_study_id>
    <nct_id>NCT02512809</nct_id>
  </id_info>
  <brief_title>Isoflurane-induced Neuroinflammation in Children With Hydrocephalus</brief_title>
  <official_title>Isoflurane-induced Neuroinflammation in Children With Hydrocephalus: A Bench-to-bedside, Translational Study of Molecular Pathways and Therapeutic Approaches</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nationwide Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will quantify inflammatory biomarkers in cerebrospinal fluid (CSF) and
      serum of children with hydrocephalus who are undergoing ventriculoperitoneal shunt placement
      under isoflurane anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background &amp; Significance. Each year, millions of children receive general anesthesia.
      Isoflurane, a GABA type A (GABAA) receptor agonist is an inhaled anesthetic commonly used in
      clinical anesthesia practice worldwide. Anesthetics traditionally have been assumed to be
      safe as long as severe hypotension and hypoxia are avoided. Interfering with the balance of
      excitatory and inhibitory neurotransmitters in the developing brain may interfere with the
      formation of synaptic connections and enhance the normal apoptotic processes that lead to
      neuronal pruning and may induce neuroinflammation. Such enhanced neuronal pruning and
      neuroinflammation could lead to excessive neuronal loss at critical times during brain
      development and consequently cause later learning disabilities. Recent reports of
      neurotoxicity induced with isoflurane have triggered significant concern about the safety of
      this agent.

      Investigations into neuroinflammation and apoptosis after anesthetic exposure in human
      children have been limited due to ethical and methodological concerns. Studies that have been
      done have been largely retrospective, population-based studies. Results from these studies
      have been mixed, some showing a decline in neurocognitive performance, some showing no
      change. Further, the vast majority of prospective, hypothesis-driven research has been
      undertaken in animal models. Developing a clinically relevant animal model and testing
      resultant hypotheses in humans are critical steps in determining the underlying cause of
      these changes as well as identifying possible therapeutic targets. The investigators
      hypothesize that piglets exposed to commonly used anesthetics will exhibit increased
      neuroinflammation when compared with controls. It is further hypothesized children undergoing
      neurosurgery with isoflurane anesthesia will show evidence of increased central nervous
      system inflammation. Finally, the investigators hypothesize that significantly less robust
      inflammation will be seen in patients undergoing MRI with general anesthesia (no surgery),
      indicating a role of surgical stress in the modulation of isoflurane-induced
      neuroinflammation.

      Clinical/Translational Investigation (NCH): Surgery Group. Patients aged 0-5 years undergoing
      general anesthesia for ventriculoperitoneal shunt (VPS) repair will have CSF and serum
      sampled at the beginning of surgery (after induction but before surgical incision) and at the
      end of surgery (after closure but before emergence). Each of these patients will be
      randomized to a standardized anesthetic. An additional CSF sample will be taken prior to post
      anesthesia care unit (PACU) discharge. These samples will be analyzed as described above.
      Control Group. Patients undergoing diagnostic MRI under general anesthesia for non-neurologic
      pathology will receive a standardized anesthetic. Serum will be collected at the beginning
      and end of the procedure and will be analyzed for inflammation as above.

      Short term goals: Demonstrate that isoflurane has a role in modulation of neuroinflammation
      in humans. Determine if surgical stress also has a role in modulation of this inflammation.
      Develop a clinically relevant animal model for hypothesis-driven anesthetic neuroinflammation
      research.

      Long term goals: Identify which anesthetic regimens, if any, are safe for use in the
      developing brain. Identify therapeutic targets for prevention or treatment of
      anesthetic-induced neuroinflammation. Obtain independent federal funding for future research
      and establish an experimental neuroscience program on the Nationwide Children's campus.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    PI moving to another institution.
  </why_stopped>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">October 31, 2017</completion_date>
  <primary_completion_date type="Actual">October 31, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Serum Cytokine Levels</measure>
    <time_frame>On the day of surgery or MRI from start of procedure to discharge from PACU (approx. 1-7 hrs.)</time_frame>
    <description>Surgery subjects will have blood collected once at the start of surgery, once at the end of surgery, and once in the PACU. MRI patients will have blood collected once prior to the start of the MRI and once at the completion of the MRI.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Toxicity</condition>
  <condition>Hydrocephalus</condition>
  <arm_group>
    <arm_group_label>Isoflurane Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pediatric patients, aged 0-5 years, diagnosed with hydrocephalus undergoing a surgical (non-bedside) shunting procedure with general anesthesia. Pts will receive a standardized general anesthetic with isoflurane.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine/remifentanil Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pediatric patients, aged 0-5 years, diagnosed with hydrocephalus undergoing a surgical (non-bedside) shunting procedure with general anesthesia. Pts will receive a standardized general anesthetic with dexmedetomidine and remifentanil infusions..</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MRI Control Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Otherwise healthy pediatric patients, aged 0-5 years, undergoing MRI with general anesthesia for evaluation of non-neurologic disease. Patients will receive a standardized general anesthetic with isoflurane.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isoflurane</intervention_name>
    <arm_group_label>Isoflurane Arm</arm_group_label>
    <other_name>Isosthesia, Forane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <arm_group_label>Dexmedetomidine/remifentanil Arm</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (HC study patients):

          -  Pediatric patients, aged 6 months-less than 11 years, diagnosed with hydrocephalus
             undergoing a primary surgical (non-bedside) shunting procedure with general
             anesthesia.

          -  Participants must have a parent/guardian who is able to provide written informed
             consent in accordance with human investigation committee guidelines.

          -  The shunting procedure must be an initial VPS placement (not a VPS revision).

        Inclusion Criteria (MRI with general anesthesia: peripheral blood patients; anesthesia but
        no surgery):

          -  Otherwise healthy pediatric patients, aged 6 months-less than 11 years, undergoing MRI
             with general anesthesia for evaluation of non-neurologic, non-inflammatory disease.

          -  Participants must have a parent/guardian who is able to provide written informed
             consent in accordance with IRB guidelines.

        Exclusion Criteria (HC study patients):

          -  Any active infection or infection within the last 14 days.

          -  Treatment in the last 48 hours with non-steroidal anti-inflammatory (NSAID) or
             corticosteroid medications.

          -  Anticoagulant administration in the last 48 hours.

          -  Treatment with any drug known to induce or suppress inflammation.

          -  Clinically unstable patients.

          -  Patients that have an American Society of Anesthesiologists physical status ≥4
             (severe, life-threatening disease).

          -  Infants born more than 4 weeks premature.

        Exclusion Criteria (MRI with general anesthesia: peripheral blood patients; anesthesia but
        no surgery):

          -  Known central nervous system disease.

          -  Treatment in the last 48 hours with non-steroidal anti-inflammatory (NSAID) or
             corticosteroid medications.

          -  Treatment with any drug known to induce or suppress inflammation.

          -  Patients that have an American Society of Anesthesiologists (ASA) physical status ≥4
             (severe, life-threatening disease).

          -  Infants born more than 4 weeks premature.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Tobias, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nationwide Children's Hospital</affiliation>
  </overall_official>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>February 23, 2015</study_first_submitted>
  <study_first_submitted_qc>July 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 31, 2015</study_first_posted>
  <results_first_submitted>November 19, 2018</results_first_submitted>
  <results_first_submitted_qc>December 12, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">December 13, 2018</results_first_posted>
  <last_update_submitted>December 12, 2018</last_update_submitted>
  <last_update_submitted_qc>December 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nationwide Children's Hospital</investigator_affiliation>
    <investigator_full_name>Joseph D. Tobias</investigator_full_name>
    <investigator_title>Chairman of Anesthesiology &amp; Pain Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocephalus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 31, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/09/NCT02512809/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>There were no participants assigned to the &quot;Isoflurane&quot; and &quot;Dexmedetomidine/Remifentanil Arm&quot; Arms/Groups as only the MRI control arm completed enrollment prior to the original PI leaving the institution and there was no enrollment in the other 2 arms.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>MRI Control Arm</title>
          <description>Otherwise healthy pediatric patients, aged 0-5 years, undergoing MRI with general anesthesia for evaluation of non-neurologic disease. Patients will receive a standardized general anesthetic with isoflurane.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Only the MRI control arm completed enrollment prior to the original PI leaving the institution. There was no enrollment in the other 2 arms.</population>
      <group_list>
        <group group_id="B1">
          <title>Isoflurane Arm</title>
          <description>Pediatric patients, aged 0-5 years, diagnosed with hydrocephalus undergoing a surgical (non-bedside) shunting procedure with general anesthesia. Pts will receive a standardized general anesthetic with isoflurane.
Isoflurane</description>
        </group>
        <group group_id="B2">
          <title>Dexmedetomidine/Remifentanil Arm</title>
          <description>Pediatric patients, aged 0-5 years, diagnosed with hydrocephalus undergoing a surgical (non-bedside) shunting procedure with general anesthesia. Pts will receive a standardized general anesthetic with dexmedetomidine and remifentanil infusions..
Dexmedetomidine</description>
        </group>
        <group group_id="B3">
          <title>MRI Control Arm</title>
          <description>Otherwise healthy pediatric patients, aged 0-5 years, undergoing MRI with general anesthesia for evaluation of non-neurologic disease. Patients will receive a standardized general anesthetic with isoflurane.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="0"/>
            <count group_id="B2" value="0"/>
            <count group_id="B3" value="25"/>
            <count group_id="B4" value="25"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="3.73" spread="2.49"/>
                    <measurement group_id="B4" value="3.73" spread="2.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="17.4" spread="8.3"/>
                    <measurement group_id="B4" value="17.4" spread="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Anesthetic Time</title>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="54.7" spread="24.7"/>
                    <measurement group_id="B4" value="54.7" spread="24.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous Anesthesia</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>American Society of Anesthesiologists (ASA) Physical Status classification</title>
          <description>ASA 1: Normal healthy patient
ASA 2: Patients with mild systemic disease
ASA 3: Patients with severe systemic disease
ASA 4: Patients with severe systemic disease that is a constant threat to life
ASA 5: Moribund patients who are not expected to survive without the operation
ASA 6: A declared brain-dead patient whose organs are being removed for donor purposes</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>ASA 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ASA 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Serum Cytokine Levels</title>
        <description>Surgery subjects will have blood collected once at the start of surgery, once at the end of surgery, and once in the PACU. MRI patients will have blood collected once prior to the start of the MRI and once at the completion of the MRI.</description>
        <time_frame>On the day of surgery or MRI from start of procedure to discharge from PACU (approx. 1-7 hrs.)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>MRI Control Arm</title>
            <description>Otherwise healthy pediatric patients, aged 0-5 years, undergoing MRI with general anesthesia for evaluation of non-neurologic disease. Patients will receive a standardized general anesthetic with isoflurane.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Serum Cytokine Levels</title>
          <description>Surgery subjects will have blood collected once at the start of surgery, once at the end of surgery, and once in the PACU. MRI patients will have blood collected once prior to the start of the MRI and once at the completion of the MRI.</description>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>IL-1β pre-isoflurane</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.97" spread="9.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-1β post-isoflurane</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.53" spread="16.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TNF-α pre-isoflurane</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.26" spread="18.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TNF-α post-isoflurane</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.84" spread="12.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6 pre-isoflurane</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.28" spread="2.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6 post-isoflurane</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.04" spread="2.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 day</time_frame>
      <group_list>
        <group group_id="E1">
          <title>MRI Control Arm</title>
          <description>Otherwise healthy pediatric patients, aged 0-5 years, undergoing MRI with general anesthesia for evaluation of non-neurologic disease. Patients will receive a standardized general anesthetic with isoflurane.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Joseph D. Tobias, MD</name_or_title>
      <organization>Nationwide Children's Hospital</organization>
      <phone>6147224200</phone>
      <email>joseph.tobias@nationwidechildrens.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

